Abstract
Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.
MeSH terms
-
Biotechnology / economics*
-
Biotechnology / statistics & numerical data*
-
Biotechnology / trends
-
Europe
-
Income / statistics & numerical data*
-
Income / trends
-
Industry / economics*
-
Industry / statistics & numerical data*
-
Industry / trends
-
Private Sector / economics*
-
Private Sector / statistics & numerical data*
-
United States